| 臺大學術典藏 |
2021-09-01T01:53:45Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.; Lin C.-C.; Huang T.-C.; ANN-LII CHENG; Yeh K.-H.; Hsu C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
|
Kim S.J.; Hsu C.; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Clinicopathologic features and responses to radiotherapy of myeloid sarcoma
|
Chen W.-Y.; Wang C.-W.; Chang C.-H.; Liu H.-H.; Lan K.-H.; Tang J.-L.; Tien H.-F.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study
|
Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; Hsu C.-H.; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Avi?a J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; ANN-LII CHENG; Chang K.-J.; Huang C.-S. |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size
|
Lin Z.-Z.; Shau W.-Y.; Hsu C.; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial
|
ANN-LII CHENG; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. |
| 臺大學術典藏 |
2021-09-01T01:53:42Z |
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
|
ANN-LII CHENG; Amarapurkar D.; Chao Y.; Chen P.-J.; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W. |
| 臺大學術典藏 |
2021-09-01T01:53:42Z |
Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy
|
Lu L.-C.; Shao Y.-Y.; Chan S.-Y.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:41Z |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:41Z |
Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP
|
Lin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG; Hsu P.-N. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
|
Lin C.-H.; Chuang P.-Y.; Chiang C.-J.; Lu Y.-S.; ANN-LII CHENG; Kuo W.-H.; Huang C.-S.; Lai M.-S.; You S.-L.; Tang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:39Z |
Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Chen R.-J.; Wang C.-W.; Chen Y.-H.; Cheng J.C.-H.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:28Z |
�]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma
|
Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:28Z |
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
|
Liu W.-L.; Gao M.; Tzen K.-Y.; Tsai C.-L.; Hsu F.-M.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
|
Ghamande S.; Lin C.-C.; Cho D.C.; Shapiro G.I.; Kwak E.L.; Silverman M.H.; Tseng Y.; Kuo M.-W.; Mach W.B.; Hsu S.-C.; Coleman T.; Yang J.C.-H.; ANN-LII CHENG; Ghalib M.H.; Chuadhary I.; Goel S. |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao Y.-Y.; Ho M.-C.; ANN-LII CHENG; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
Reply
|
Hsu C.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:26Z |
Preoperative Prognostic Neurologic Index for Glioblastoma Patients Receiving Tumor Resection
|
Liang H.-K.; Wang C.-W.; Tseng H.-M.; Huang C.-Y.; Lan K.-H.; Chen Y.-H.; You S.-L.; Cheng J.C.-H.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:26Z |
Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer
|
Chen K.-H.; Shao Y.-Y.; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; Yeh K.-H.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:26Z |
Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior
|
Huang W.-T.; Kuo S.-H.; ANN-LII CHENG; Lin C.-W. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen T.W.-W.; Chen H.-M.; Lin C.-H.; Huang C.-S.; ANN-LII CHENG; Lai M.-S.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma
|
Liao F.; Hsu Y.-C.; Kuo S.-H.; Yang Y.-C.; Chen J.-P.; Hsu P.-N.; Lin C.-W.; Chen L.-T.; ANN-LII CHENG; Fann C.S.J.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:24Z |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; Yeh K.-H.; Chen L.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:24Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; Yang P.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:24Z |
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin
|
Ou D.-L.; Lee B.-S.; Lin L.-I.; Liou J.-Y.; Liao S.-C.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Clinical activity of metronomic chemotherapy in liver cancers
|
Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
|
Shao Y.-Y.; Wu C.-H.; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
erratum: Oxidative stress enhances AXL-mediated cell migration through AKT1/Rac1-dependent mechanism (Free Radical Biology and Medicine (2013) 65 (1246-1256))
|
Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E. |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption
|
Lin Z.-Z.; Chou C.-H.; ANN-LII CHENG; Liu W.-L.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:21Z |
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
|
Chen Y.-H.; Wei M.-F.; Wang C.-W.; Lee H.-W.; Pan S.-L.; Gao M.; Kuo S.-H.; ANN-LII CHENG; Teng C.-M. |
| 臺大學術典藏 |
2021-08-31T06:42:21Z |
Recent advances in the prevention of hepatocellular carcinoma recurrence
|
Lu L.-C.; ANN-LII CHENG; Poon R.T.P. |
| 臺大學術典藏 |
2021-08-31T06:42:21Z |
Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus
|
ANN-LII CHENG; Li J.; Vaid A.K.; Ma B.B.Y.; Teh C.; Ahn J.B.; Bello M.; Charoentum C.; Chen L.-T.; De Lima Lopes G.; Jr.; Ho G.F.; Kong H.L.; Lam K.O.; Liu T.S.; Park Y.S.; Sriuranpong V.; Sudoyo A.W.; Wang J.-Y.; Zhang J.; Zhang S.Z.; Ciardiello F.; K?hne C.-H.; Shaw M.; Kim T.W. |
| 臺大學術典藏 |
2021-08-31T06:42:21Z |
The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells
|
Lin Y.-H.; Chen B.Y.-H.; Lai W.-T.; Wu S.-F.; Guh J.-H.; ANN-LII CHENG; Hsu L.-C. |
| 臺大學術典藏 |
2021-08-31T06:42:20Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Wu M.-S.; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:20Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang T.C.; Shiah H.S.; Yang C.H.; Yeh K.H.; ANN-LII CHENG; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T. |
| 臺大學術典藏 |
2021-08-31T06:42:20Z |
Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma
|
Liao B.-C.; Shao Y.-Y.; Chen H.-M.; Shau W.-Y.; Lin Z.-Z.; Kuo R.N.; Lai C.-L.; Chen K.-H.; ANN-LII CHENG; Yang J.C.-H.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:19Z |
Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma
|
Tsai C.-L.; Hsu F.-M.; Tzen K.-Y.; Liu W.-L.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:19Z |
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials
|
Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; Lu L.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:18Z |
Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou D.-L.; Shyue S.-K.; Lin L.-I.; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; Lin C.-H.; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells
|
Tsai Y.-C.; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:50Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; ANN-LII CHENG; Yeh K.-H. |
